Paris, France

Dominique Schweizer



Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Dominique Schweizer

Introduction

Dominique Schweizer is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical compounds. With a total of three patents to his name, his work has implications for various medical treatments.

Latest Patents

Schweizer's latest patents include a process for the enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation. This invention relates to a method for preparing a sulphoxide compound, either as a single enantiomer or in an enantiomerically enriched form. Another significant patent involves thio-substituted biarylmethanesulfinyl derivatives, which are related to chemical compositions and processes for their preparation. These compositions have potential uses in treating various diseases, including narcolepsy, Parkinson's disease, and Alzheimer's disease, among others.

Career Highlights

Throughout his career, Dominique Schweizer has worked with prominent companies such as Cephalon, Inc. and Cephalon France. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Philippe Louvet and Edward R Bacon. Their collaboration has likely contributed to the advancement of his research and inventions.

Conclusion

Dominique Schweizer's work exemplifies the impact of innovation in the field of chemistry, particularly in developing treatments for various neurological conditions. His patents reflect a commitment to advancing medical science through inventive processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…